In Brief: Unipath Diagnostics
This article was originally published in The Tan Sheet
Executive Summary
Unipath Diagnostics: Patricia Nasshorn to president of the Unilever reproductive diagnostics division. She formerly was VP-marketing at J&J's Direct Access Diagnostics, which marketed the discontinued Confide home HIV test. Nasshorn succeeds Alastair Paton, Unipath's general manager, who will oversee the company's business development outside the U.S. and Europe. Unipath is conducting clinical trials for an electronic monitor system for birth control ("The Tan Sheet" June 9, p. 4). Work also is under way on a fertility monitor that employs the same technology. Unipath reacquired the Clearblue Easy home pregnancy test and Clearplan Easy ovulation predictor from Whitehall-Robins upon its formation in January and launched the Clearblue Easy One Minute pregnancy test in May. The firm plans to move its headquarters from New York City to Princeton, N.J. in 1998...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning